Document:

Exhibit 4.40

Exhibit 4.40

SHARE PURCHASE AGREEMENT

BY AND BETWEEN

AGRIA CORPORATION

AND

XUE ZHIXIN

July 13, 2010

 

 

 

TABLES OF CONTENTS

	 	 	 	 	 
	 	 	Pages	 
	ARTICLE I DEFINITIONS
	 	 	1	 
	SECTION 1.01. Certain Defined Terms
	 	 	1	 
	ARTICLE II PURCHASE AND SALE
	 	 	3	 
	SECTION 2.01. Purchase and Sale
	 	 	3	 
	SECTION 2.02. Purchase Price
	 	 	3	 
	SECTION 2.03. Closing
	 	 	3	 
	SECTION 2.04. Deliveries at the Closing
	 	 	3	 
	ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER
	 	 	4	 
	SECTION 3.01. Authority to Execute and Perform this Agreement
	 	 	4	 
	SECTION 3.02. Transferred Shares
	 	 	4	 
	SECTION 3.03. No Conflicts
	 	 	4	 
	SECTION 3.04. Controlling Agreements
	 	 	4	 
	ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
	 	 	5	 
	SECTION 4.01. Authority to Execute and Perform this Agreement
	 	 	5	 
	ARTICLE V UNDERTAKINGS
	 	 	5	 
	SECTION 5.01. Confidentiality
	 	 	5	 
	SECTION 5.02. Consents and Approvals in relation to the Lease Transfer Agreements
	 	 	5	 
	ARTICLE VI CONDITIONS PRECEDENT
	 	 	6	 
	SECTION 6.01. Conditions Precedent to the Obligations of the Seller and the Purchaser
	 	 	6	 
	SECTION 6.02. Conditions Precedent to the Purchaser’s Obligations
	 	 	6	 
	SECTION 6.03. Conditions Precedent to the Seller’s Obligations
	 	 	7	 
	ARTICLE VII INDEMNIFICATION
	 	 	7	 
	SECTION 7.01. Indemnification by the Seller
	 	 	7	 
	SECTION 7.02. Indemnification by the Purchaser
	 	 	7	 
	ARTICLE VIII GENERAL PROVISIONS
	 	 	8	 
	SECTION 8.01. Expenses
	 	 	8	 
	SECTION 8.02. Termination
	 	 	8	 
	SECTION 8.03. Notices
	 	 	8	 
	SECTION 8.04. Severability
	 	 	8	 
	SECTION 8.05. Amendment
	 	 	9	 
	SECTION 8.06. Governing Law, Arbitration
	 	 	9	 
	SECTION 8.07. Assignment and Succession
	 	 	9	 
	SECTION 8.08. Headings
	 	 	9	 
	SECTION 8.09. Language
	 	 	9	 

 

 

 

SHARE PURCHASE AGREEMENT

This SHARE PURCHASE AGREEMENT (this “Agreement”) is entered into on July 13, 2010,
between Mr. Xue Zhixin (a Chinese citizen who ID number is 140102196210230813) (the
“Seller”), and Agria Corporation, a company organized and existing under the laws of Cayman
Islands (the “Purchaser”).

RECITALS:

WHEREAS,
Primalights III Agriculture Development Co., Ltd. (the “Company”) is a
company organized and existing under the laws of the People’s Republic of China (the
“PRC”). Through its wholly-owned enterprise, Aero-Biotech Science & Technology Co., Ltd.
(“Aero-Biotech”), a foreign-owned enterprise organized under the laws of the PRC, which
entered into certain agreements with the Company on June 8, 2007 as set forth in Exhibit I attached
hereto (the “Controlling Agreements”), the Seller exercises actual control over the Company
and receives all of the economic benefits of the Company;

WHEREAS, the Seller legally owns 21,943,040 ordinary shares of the Purchaser; and

WHEREAS, the Seller wishes to sell to the Purchaser, and the Purchaser wishes to purchase from
the Seller, 14,393,400 ordinary shares of the Purchaser owned by the Seller, representing 11.5% of
the Purchaser’s issued shares (the
“Transferred Shares”), subject to the terms and the
conditions set forth in this Agreement;

NOW, THEREFORE, in consideration of the mutual promises, representations, warranties,
agreements and covenants set forth in this Agreement and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto mutually agree as
follows:

ARTICLE I

DEFINITIONS

SECTION 1.01. Certain Defined Terms

Aero-Biotech has the meaning specified in the recitals of this Agreement.

Affiliate means, with respect to a specified person, any other person that directly or
indirectly controls, is controlled by or is under common control with such specified person.

Agreement has the meaning specified in the preamble of this Agreement.

Closing has the meaning specified in Section 2.01.

Closing Date has the meaning specified in Section 2.03.

 

1

 

Company has the meaning specified in the recitals of this Agreement.

Controlling Agreements has the meaning specified in the recitals of this Agreement.

Equity Pledge Agreement means the equity pledge agreement entered into among and between the
Company, the Company’s shareholders, namely, Li Juan, Qian Zhaohua, Xue Zhixin and Zhang Mingshe,
and Aero-Biotech on June 8, 2007, as amended from time to time.

Exclusive Call Option has the meaning specified in Section 2.02.

Exclusive Call Option Agreement means the exclusive call option agreement entered into among
and between the Company, the Company’s shareholders, namely, Li Juan, Qian Zhaohua, Xue Zhixin and
Zhang Mingshe, and Aero-Biotech on June 8, 2007, as amended from time to time.

Exclusive Consultancy Service Agreement means the exclusive consultancy service agreement
entered into between the Company and Aero-Biotech on June 8, 2007, as amended from time to time.

Exclusive Technology Development, Technology Support and Technology Service Agreement means
the exclusive technology development, technology support and technology service agreement entered
into between the Company and Aero-Biotech on June 8, 2007, as amended from time to time.

Governmental Authority means any court, tribunal, arbitrator, authority, agency, commission,
official or other instrumentality of the PRC, any foreign country or any domestic or foreign state,
province, county, city or other political subdivision.

Law means any publicly promulgated applicable statute, law, ordinance, regulation, rule, code,
order, other requirement or rule of law.

Lease Transfer Agreements have the meaning specified in Section 6.02.

Letter of Undertaking means the letter of undertaking signed by the Company’s shareholders,
namely, Li Juan, Qian Zhaohua, Xue Zhixin and Zhang Mingshe on July 13, 2007, as amended from time
to time.

Lien means any mortgage, deed of trust, pledge, hypothecation, assignment, encumbrance, lien
(statutory or other) or preference, priority, right or other security interest or preferential
arrangement of any kind or nature whatsoever.

Losses has the meaning specified in Section 7.01.

New Letter of Undertaking means the letter of undertaking in the form of attached hereto as
Appendix F signed by Aero-Biotech.

Power of Attorney means the power of attorney signed by the Company’s shareholders, namely, Li
Juan, Qian Zhaohua, Xue Zhixin and Zhang Mingshe on June 8, 2007, as amended from time to time.

PRC has the meaning specified in the recitals of this Agreement.

 

2

 

Proprietary Technology License Agreement means the proprietary technology agreement entered
into between the Company and Aero-Biotech on June 8, 2007, as amended from time to time.

Purchaser has the meaning specified in the preamble of this Agreement.

Purchaser Indemnified Parties has the meaning specified in Section 7.01.

Seller has the meaning specified in the preamble of this Agreement.

Seller Indemnified Parties has the meaning specified in Section 7.02.

Transferred Shares has the meaning specified in the recitals of this Agreement.

ARTICLE II

PURCHASE AND SALE

SECTION 2.01. Purchase and Sale

Subject to the terms and conditions of this Agreement, at the closing of the transactions
contemplated by this Agreement (the “Closing”), the Seller shall sell and transfer to the
Purchaser, and the Purchaser shall purchase from the Seller, all of the Seller’s right, title and
interest in and to the Transferred Shares (i.e., 14,393,400 ordinary shares of the Purchaser), free
and clear of any Liens except for restrictions of general applicability imposed by federal, state
and foreign securities laws.

SECTION 2.02. Purchase Price

The purchase price for the Transferred Shares shall be the following:

The Purchaser shall cause Aero-Biotech to assign and transfer to the Seller all of all of its
right, title and interest in, to and under, and delegates to the Seller all of its duties,
liabilities and obligations under the Exclusive Call Option Agreement (the aforementioned right,
title, interest, duties, obligations and liabilities, collectively, the “Exclusive Call
Option”). The Seller accepts and assumes such Exclusive Call Option as the full consideration
for the sale of the Transferred Shares, and agrees to be bound by the terms of the Exclusive Call
Option Agreement.

SECTION 2.03. Closing 

The Closing of the purchase and sale of Shares shall take place in Taiyuan, Shanxi Province,
China on July 13, 2010, or later as agreed by the Seller and the Purchaser (the “Closing
Date”).

SECTION 2.04. Deliveries at the Closing

At the Closing, the Seller shall deliver, or shall cause to be delivered, to Purchaser the
following:

(i) original share certificates representing the Transferred Shares held by the Seller;

(ii) the bill of transfer evidencing the transfer of Transferred Shares by the Seller
to the Purchaser;

(iii) documents required in Section 6.01 (a) to Section 6.01 (f).

 

3

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE SELLER

The Seller hereby represents and warrants to the Purchaser as follows:

SECTION 3.01. Authority to Execute and Perform this Agreement

The execution and delivery of this Agreement by the Seller, the performance by the Seller of
its obligations hereunder and the consummation by the Seller of the transactions contemplated
hereby have been duly authorized by all requisite actions on the part of the Seller. This
Agreement has been duly executed and delivered by the Seller, and this Agreement constitutes a
legal, valid and binding obligation of the Seller enforceable against the Seller in accordance with
its terms.

SECTION 3.02. Transferred Shares

The Seller legally and beneficially owns all of the Transferred Shares, and such Transferred
Shares are free and clear of any Liens except for restrictions of general applicability imposed by
federal, state and foreign securities laws (and contractual restrictions imposed by this Agreement,
any lock-up agreements as is known or disclosed to the Purchaser). The Transferred Shares are not
subject to any voting trust or other agreement, commitment or arrangement relating to the voting
thereof.

SECTION 3.03. No Conflicts

The execution, delivery and performance by the Seller of this Agreement and the consummation
by the Seller of the transactions contemplated hereby and thereby do not and will not: (a) violate,
conflict with or result in a breach of, or constitute a default (or create an event which, with
notice or lapse of time or both, would constitute a default) or give rise to any right of
termination, cancellation or acceleration under, or result in the creation of any encumbrance on
the Transferred Shares under, any note, bond, mortgage, indenture, deed of trust, license,
franchise, permit, lease, contract, agreement or other instrument to which the Seller is bound; (b)
violate or result in a breach of any Law applicable to the Seller. No consents, permits, waivers
or authorizations of Governmental Authorities or other related parties are required for the
execution, delivery and performance by the Seller of this Agreement and the consummation of the
transactions contemplated hereunder by the Seller.

SECTION 3.04. Controlling Agreements

The Controlling Agreements remain valid, effective and binding as of the date of this
Agreement. None of the Seller, the Company or the record shareholders of the Company: (i)
committed any misconducts or any conducts that may cause any violation, conflict with or breach of,
or default by the Company or its record shareholders under the Controlling Agreement; or (ii)
entered into any contracts, agreements or arrangements related to any matter referred to in or
contemplated by the Controlling Agreements outside of the control or the knowledge of the
Purchaser. The Seller is not aware of any breach of fiduciary duty or other inappropriate conducts
by any current or former directors and officers of the Purchaser or the Company.

 

4

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE PURCHASER

The Purchaser hereby represents and warrants to the Seller as follows:

SECTION 4.01. Authority to Execute and Perform this Agreement

The execution and delivery of this Agreement by the Purchaser, the performance by the
Purchaser of its obligations hereunder and the consummation by the Purchaser of the transactions
contemplated hereby have been duly authorized by all requisite action on the part of the Purchaser.
This Agreement has been duly executed and delivered by the Purchaser, and upon coming into effect,
this Agreement constitutes a legal, valid and binding obligation of the Purchaser enforceable
against the Purchaser in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and similar Laws of general applicability relating to or
affecting creditors’ rights and to general equity principles.

ARTICLE V

UNDERTAKINGS

SECTION 5.01. Confidentiality

The Seller agrees to keep this Agreement and the transactions contemplated under this
Agreement strictly confidential and to cause its representatives, partners, consultants (including
financial consultants, legal consultants and accountants) and its Affiliates to keep this Agreement
and related negotiations strictly confidential. Further, the Seller agrees and undertakes that it
shall not, without the consent of the Purchaser, disclose or permit the disclosure to any third
party of any information relating to the existence of this Agreement or of any negotiations in
relation to the same, or of any other matters referred to in or contemplated by this Agreement,
save where disclosure is required by law, a stock exchange or other regulator, a court of competent
jurisdiction or any Governmental Authority. The Seller agrees and undertakes that it shall not,
directly or indirectly, make any explicit or implied comments that may have a negative impact on
the reputation of the Purchaser or the Company or the share price of the Purchaser before and after
the consummation of the transactions contemplated herein. Notwithstanding the foregoing, the
Purchaser may, without the consent of the Seller, disclose or permit the disclosure to any third
party of any information relating to the existence of this Agreement or of any negotiations in
relation to the same, or of any other matters referred to in or contemplated by this Agreement as
it deems appropriate.

SECTION 5.02. Consents and Approvals in relation to the Lease Transfer Agreements

The Seller will cause the Company to use its best efforts to obtain all consents, approvals
and permits from third parties and Governmental Authorities required to effect the transactions
contemplated under the Lease Transfer Agreements.

 

5

 

ARTICLE VI

CONDITIONS PRECEDENT

SECTION 6.01. Conditions Precedent to the Obligations of the Seller and the
Purchaser

The obligations of the Seller and the Purchaser to complete the Closing, unless otherwise
waived in writing by such party, are subject to the fulfillment of each of the following conditions
on or before the Closing Date:

(a) the Seller and Aero-Biotech have signed the Assignment and Assumption Agreement regarding
the Exclusive Call Option dated as of the date of this Agreement in the form of attached hereto as
Appendix A;

(b) the Seller and Aero-Biotech have signed the Assignment and Assumption Agreement regarding
the Exclusive Technology Development, Technology Support and Technology Service Agreement dated as
of the date of this Agreement in the form attached hereto as Appendix B, pursuant to which,
Aero-Biotech shall transfer and assign all its rights and obligations contained under the Exclusive
Technology Development, Technology Support and Technology Service agreement;

(c) Aero-Biotech has signed and delivered the Termination Notice dated as of the date of this
Agreement in the form attached hereto as Appendix C to terminate the Exclusive Consultancy Service
Agreement;

(d) Aero-Biotech has signed and delivered the Termination Notice dated as of the date of this
Agreement in the form attached hereto as Appendix D to terminate the Proprietary Technology License
Agreement;

(e) Aero-Biotech has delivered the Termination Notice dated as of the date of this Agreement
in the form attached hereto as Appendix E to terminate the Equity Pledge Agreement; and

(f) Aero-Biotech has signed the New Letter of Undertaking dated as of the date of this
Agreement in the form attached hereto as Appendix F. Pursuant to the New Letter of Undertaking,
Aero-Biotech shall undertake that to the extent that Aero-Biotech receives any dividends, interests
or other distributions from the Company which are transferred by the Company’s shareholders
pursuant to a Letter of Undertaking dated July 13, 2007, Aero-Biotech will transfer all of such
amounts to Mr. Xue Zhixin.

SECTION 6.02. Conditions Precedent to the Purchaser’s Obligations

In addition to the conditions set forth in Section 6.01, the obligations of the Purchaser to
complete the Closing, unless otherwise waived in writing by the Purchaser, are subject to the
fulfillment of each of the following conditions on or before the Closing Date:

(a) the Seller shall have delivered the Transferred Shares;

(b) the representations and warranties of the Seller shall be true and correct on the Closing
Date; and

 

6

 

(c) the
Lease Transfer Agreements (the “Lease Transfer Agreements”) in the form
attached hereto as Appendix G between the Company and the Purchaser or the company designated by
the Purchaser shall have become effective.

SECTION 6.03. Conditions Precedent to the Seller’s Obligations

In addition to the conditions set forth in Section 6.01, the obligations of the Seller to
complete the Closing, unless otherwise waived in writing by the Seller, are subject to the
fulfillment of each of the following conditions on or before the Closing Date:

(a) the representations and warranties of the Purchaser shall be true and correct on the
Closing Date.

ARTICLE VII

INDEMNIFICATION

SECTION 7.01. Indemnification by the Seller

The Seller agrees to promptly indemnify and hold harmless the Purchaser, and its officers,
directors, partners, affiliates, attorneys and representatives (collectively, the “Purchaser
Indemnified Parties”) from, against, for and in respect of and pay any and all damages, awards,
judgments, assessments, fines penalties, charges, costs and expenses and other payments (the
“Losses”) suffered, sustained, incurred or required to be paid by any such party arising
out of or resulting from (i) any material breach of any representation, warranty, covenant or
agreement of the Seller contained in this Agreement; (ii) any violation, conflict with or breach of
the organizational documents of the Company or the Controlling Agreements by the Company or the
Seller; (iii) any violation, conflict with or breach of, or default by the Company or the Seller
under any note, bond, mortgage, indenture, deed of trust, license, franchise, permit, lease,
contract, agreement or other instrument to which the Company, the Seller or any of their respective
properties is bound; (iv) any violation or breach of any Law applicable to the Company, the Seller
or any of their respective properties; or (v) any wrongful act committed by the Seller or the
Company.

SECTION 7.02. Indemnification by the Purchaser

The Purchaser agrees to promptly indemnify and hold harmless the Seller, and its officers,
directors, partners, affiliates, attorneys and representatives
(collectively, the “Seller
Indemnified Parties”) from, against, for and in respect of and pay any and all Losses suffered,
sustained, incurred or required to be paid by any such party arising out of or resulting from any
material breach of any representation, warranty, covenant or agreement of the Purchaser contained
in this Agreement.

 

7

 

ARTICLE VIII

GENERAL PROVISIONS

SECTION 8.01. Expenses

All costs and expenses, including but not limited to, fees and disbursements of counsel,
financial advisors and accountants, incurred in connection with this Agreement and the transactions
contemplated hereby shall be paid by the party incurring such costs and expenses.

SECTION 8.02. Termination

The Seller or the Purchaser may terminate this Agreement at any time before the Closing by
mutual written consent.

SECTION 8.03. Notices

All notices, requests, claims, demands and other communications hereunder will be in writing
and will be given or made (and will be deemed to have been duly given or made upon receipt) by
delivery in person, by courier service, by confirmed telecopy (with a copy sent by another means
specified herein), or by registered or certified mail (postage prepaid, return receipt requested)
to the parties at the following addresses (or at such other address for a party as will be
specified by like notice):

	 	 	 	 	 
	 

	 	If to the Seller:	 	 
	 
	 	 	 	 
	 

	 	 	 	Xue Zhixin

Address: 25th Floor, Jin Gang Hotel,

No.91 Bing Zhou North Road,

Taiyuan City, Shanxi Province

	 
	 	 	 	 
	 

	 	 	 	Fax: 0351-4727112
	 
	 	 	 	 
	 

	 	If to the Purchaser:	 	 
	 
	 	 	 	 
	 

	 	 	 	Agria Corporation

Address: 21/F Tower B, PingAn International
 Finance Center, 1-3
Xinyuan South Road,
 Chaoyang District, Beijing, China

	 
	 	 	 	 
	 

	 	 	 	Attn: Xie Tao
	 
	 	 	 	 
	 

	 	 	 	Fax: 010-84381003

SECTION 8.04. Severability

If any term or other provision of this Agreement is invalid, illegal or incapable of being
enforced by any Law or public policy, all other terms and provisions of this Agreement shall
nevertheless remain in full force and effect so long as the economic or legal substance of the
transactions contemplated hereby is not affected in any manner materially adverse to either party
hereto. Upon such determination that any term or other provision is invalid, illegal or incapable
of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as
to effect the original intent of the parties as closely as possible in an acceptable manner in
order that the transactions contemplated hereby are consummated as originally contemplated to the
greatest extent possible.

 

8

 

SECTION 8.05. Amendment

This Agreement may not be amended or modified except by an instrument in writing signed by, or
on behalf of, the Seller and the Purchaser.

SECTION 8.06. Governing Law, Arbitration

This Agreement shall be governed by, and construed in accordance with, the Laws of the New
York State of the U.S., expect for its conflict laws. In the event that a dispute arises in
connection with the interpretation or implementation of this Agreement, the parties shall attempt
in the first instance to resolve such dispute through friendly consultations. If the dispute is
not resolved through consultations within sixty (60) days after any party has served a written
notice on the other parties requesting the commencement of consultations, then any party may submit
the dispute for arbitration to the Hong Kong International Arbitration Centre in accordance with
its rules in force at the time a particular dispute is submitted for arbitration, which rules shall
be deemed to have been incorporated by reference into this clause. The Seller expressly consents
to the jurisdiction of the Hong Kong International Arbitration Centre. The Chinese and English
versions of this Agreement shall be referred to in the arbitration, and all proceedings in any such
arbitration shall be conducted in English. The arbitration award shall be final, binding and
non-appealable on the parties. The costs of arbitration shall be borne by the losing party or
parties unless otherwise determined by the arbitration award. When any dispute occurs and when any
dispute is under arbitration, except for the matters under dispute, the parties shall continue to
exercise their other respective rights and fulfill their other respective obligations under this
Agreement.

SECTION 8.07. Assignment and Succession

This Agreement may not be assigned by operation of Law or otherwise without the express
written consent of the other party (which consent may be granted or withheld in the sole discretion
of such party). This Agreement shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and permitted assigns.

SECTION 8.08. Headings

The descriptive headings contained in this Agreement are for convenience of reference only and
shall not affect in any way the meaning or interpretation of this Agreement.

SECTION 8.09. Language

This Agreement is written in the Chinese language.

[SIGNATURE PAGES TO FOLLOW]

 

9

 

IN WITNESS WHEREOF, the Purchaser and the Seller have caused this Agreement to be executed by their
duly authorized representatives as of the date first written above.

	 	 	 	 	 
	 	Seller:

 	 
	 	By:  	/s/ Xue Zhixin
 	 
	 	 	Name:  	Xue Zhixin 	 
	 	 	 	 
	 	Purchaser:

AGRIA CORPORATION

 	 
	 	By:  	/s/ Xie Tao
 	 
	 	 	Name:  	Xie Tao 	 
	 	 	Title:  	Chief Executive Officer 	 

 

10

 

EXHIBIT I CONTROLLING AGREEMENTS

	1.	 	Power of Attorney

	 
	2.	 	Equity Pledge Agreement

	 
	3.	 	Exclusive Call Option Agreement

	 
	4.	 	Exclusive Technology Development, Technology Support and Technology Service
Agreement

	 
	5.	 	Exclusive Consultancy Service Agreement

	 
	6.	 	Proprietary Technology License Agreement

	 
	7.	 	Letter of Undertaking

 

11

 

	 	 	 
	Appendix A:

	 	Assignment and Assumption Agreement regarding the Exclusive Call Option Agreement
	 
	 	 
	Appendix B:

	 	Assignment and Assumption Agreement regarding the Exclusive Technology Development, Technology Support and
Technology Service Agreement
	 
	 	 
	Appendix C:

	 	Termination Notice regarding the Exclusive Consultancy Service Agreement
	 
	 	 
	Appendix D:

	 	Termination Notice regarding the Proprietary Technology License Agreement
	 
	 	 
	Appendix E:

	 	Termination Notice regarding the Equity Pledge Agreement
	 
	 	 
	Appendix F:

	 	New Letter of Undertaking
	 
	 	 
	Appendix G:

	 	Lease Transfer Agreements

 

12Exhibit 4.41

Exhibit 4.41

ASSIGNMENT AND ASSUMPTION AGREEMENT

REGARDING THE CALL OPTION

THIS ASSIGNMENT AND ASSUMPTION AGREEMENT REGARDING THE CALL OPTION (this “Assignment”) is
entered into on July 13, 2010, between Aero-Biotech Science & Technology Co., Ltd. (the
“Assignor”), a wholly foreign-owned enterprise organized in Beijing, China under the laws of the
PRC and Mr. Xue Zhixin (Chinese citizen, ID number 140102196210230813) (the “Assignee”).

WHEREAS, the Assignor and the shareholders of Primalights III Agriculture Development Co.,
Ltd. (“P3A”) are parties to certain Exclusive Call Option Agreement dated as of June 8, 2007 (as
amended from time to time, the “Exclusive Call Option Agreement”), pursuant to which the Assignor
was granted an option to purchase or causes any person or persons its designated to purchase from
the shareholders of P3A at any time all of their equity interests in P3A (the “Exclusive Call
Option”) upon certain conditions satisfied, and the Assignor has the right to transfer its rights
and obligations under the Exclusive Call Option Agreement to any third party by delivering a
written notice, without prior written consent from P3A or its shareholders;

WHEREAS, Agria Corporation, a company organized and existing under the laws of Cayman Islands
(“Agria”) and the Assignee are parties to certain share purchase agreement (the “Share Purchase
Agreement”) dated as of the date of this Assignment, pursuant to which Agria and the Assignee agree
to transfer all rights and obligations of the Assignor under the Exclusive Call Option Agreement as
the consideration payable by Agria to purchase certain shares of Agria owned by the Assignee;

WHEREAS, the Assignor desires to assign, and the Assignee desires to assume, the rights and
obligations under the Exclusive Call Option Agreement on terms and conditions set forth therein;

NOW, THEREFORE, in consideration of the foregoing premises and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as
follows, and capitalized terms used, but not otherwise defined herein, shall have the meaning
ascribed to them in the Exclusive Call Option Agreement and the Share Purchase Agreement:

	 	1.	 	Assignment and Assumption

The Assignor hereby assigns and transfers to the Assignee all of all of its right,
title and interest in, to and under, and delegates to Assignee all of its duties,
liabilities and obligations under, the Exclusive Call Option Agreement at the
closing of the transactions contemplated by this Assignment (the “Closing”), upon
the terms and subject to the conditions set forth in this Assignment, and the
Assignee hereby accepts and assumes all of Assignor’s rights, titles and interests
in, to and under, and all of Assignor’s duties, liabilities and obligations under
the Exclusive Call Option Agreement and agrees to perform under and be bound by the
terms of the Exclusive Call Option Agreement.

 

 

 

	 	2.	 	Consideration

The Assignee agrees that completion of the assignment and assumption of the
Exclusive Call Option pursuant to this Assignment shall constitute the fully payment
of the consideration payable by Agria to the Assignee pursuant to the Share Purchase
Agreement.

	 	3.	 	Closing

The Closing of the purchase and sale of Shares shall take place in Taiyuan, Shanxi
Province, China on July 13, 2010 or later as agreed by the Seller and the Purchaser
(the “Closing Date”).

	 	4.	 	Representations and Warranties

	 	a.	 	The Assignor represents and warrants to the Assignee that:

	 	(i)	 	it has not assigned, mortgaged, pledged,
encumbered, or otherwise hypothecated any of its right, title or
interest under the Exclusive Call Option Agreement, except as set forth
in this Assignment;

	 
	 	(ii)	 	the execution, delivery and performance of this
Assignment, including but not limited to the consummation of the
transactions contemplated hereby and thereby do not and will not
violate, conflict with or result in a breach of, or constitute a
default (or create an event which, with notice or lapse of time or
both, would constitute a default in the Exclusive Call Option
Agreement) of the terms, conditions or provisions under the Exclusive
Call Option Agreement; and

	 
	 	(iii)	 	the Assignor has full power and authority to
enter into this Assignment, perform the obligations of such party
hereunder and consummate the transactions contemplated hereby. All
necessary and appropriate action has been taken by such party with
respect to the execution and delivery of this Assignment. This
Assignment constitutes the valid and binding obligation of such party
enforceable in accordance with the terms hereof, subject to bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and similar
laws of general applicability relating to or affecting creditors’
rights and to general equity principles.

	 	b.	 	the Assignee represents and warrants to the Assignor that it
has full power and authority to enter into this Assignment, perform the
obligations of such party hereunder and consummate the transactions
contemplated hereby. All necessary and appropriate action has been taken by
such party with respect to the execution and delivery of this Assignment. This
Assignment constitutes the valid and binding obligation of such party
enforceable in accordance with the terms hereof, subject to bankruptcy,
insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability
relating to or affecting creditors’ rights and to general equity principles.

 

2

 

	 	5.	 	Conditions Precedent

	 	a.	 	the obligations of the Assignor to complete the Closing, unless
otherwise waived in writing by the Assignor, are subject to the fulfillment of
each of the following conditions on or before the Closing Date:

	 	(i)	 	the representations and warranties of the
Assignee shall be true and correct on the Closing Date;

	 
	 	(ii)	 	the Share Purchase Agreement has been fully
executed;

	 
	 	(iii)	 	the documents required in Section 6.01(a) to
Section 6.01(f) under the Share Transfer Agreement have been fully
executed; and

	 
	 	(iv)	 	the conditions required in Section 6.02 under
the Share Transfer Agreement have been satisfied.

	 	b.	 	The obligations of the Assignee to complete the Closing, unless
otherwise waived in writing by the Assignee, are subject to the fulfillment of
each of the following conditions on or before the Closing Date:

	 	(i)	 	the representations and warranties of the
Assignor shall be true and correct on the Closing Date;

	 
	 	(ii)	 	the Share Purchase Agreement has been fully
executed; and

	 
	 	(iii)	 	the conditions required in Section 6.03 under
the Share Transfer Agreement have been satisfied.

	 	6.	 	Termination

This Assignment shall be terminated at any time prior to the Closing by a mutual
written consent of the Assignor and the Assignee.

	 	7.	 	Expense

All costs and expenses, including but not limited to, fees and disbursements of
counsel, financial advisors and accountants, incurred in connection with this
Assignment and the transactions contemplated hereby shall be paid by the party
incurring such costs and expenses.

 

3

 

	 	8.	 	Severability

If any term or other provision of this Assignment is invalid, illegal or incapable
of being enforced by any law or public policy, all other terms and
provisions of this Assignment shall nevertheless remain in full force and effect so
long as the economic or legal substance of the transactions contemplated hereby is
not affected in any manner materially adverse to either party hereto. Upon such
determination that any term or other provision is invalid, illegal or incapable of
being enforced, the parties hereto shall negotiate in good faith to modify this
Assignment so as to effect the original intent of the parties as closely as possible
in an acceptable manner in order that the transactions contemplated hereby are
consummated as originally contemplated to the greatest extent possible.

	 	9.	 	Amendment

This Assignment may not be amended or modified except by an instrument in writing
signed by, or on behalf of, the Assignor and the Assignee.

	 	10.	 	Assignment and Succession

This Assignment may not be assigned by operation of Law or otherwise without the
express written consent of the other party (which consent may be granted or withheld
in the sole discretion of such party). This Assignment shall be binding upon and
inure to the benefit of the parties hereto and their respective successors and
permitted assigns.

	 	11.	 	Governing Law, Arbitration

This Agreement shall be governed by, and construed in accordance with, the Laws of
the People’s Republic of China. In the event that a dispute arises in connection
with the interpretation or implementation of this Agreement, the parties shall
attempt in the first instance to resolve such dispute through friendly
consultations. If the dispute is not resolved through consultations within thirty
(30) days after any party has served a written notice on the other parties
requesting the commencement of consultations, then any party may submit the dispute
for arbitration to the China International Economic and Trade Arbitration Commission
in accordance with its rules in force at the time. The arbitration shall take place
in Beijing and be conducted in Chinese. The arbitration award shall be final,
binding and non-appealable on the parties.

 

4

 

	 	12.	 	Notices

All notices, requests, claims, demands and other communications made in accordance
with this Agreement hereunder will be in writing (Chinese or English) and will be
given or made and will be deemed to have been duly given or made upon receipt by
delivery in person, by courier service, by confirmed telecopy (with a copy sent by
another means specified herein), or by registered or certified mail (postage
prepaid, return receipt requested) to the parties at the following addresses or at
such other address for a party as will be specified by like notice.

	 	 	 	 	 
	 

	 	If to the Assignor:	 	 
	 
	 	 	 	 
	 

	 	 	 	Aero-Biotech Science & Technology Co., Ltd.

Address: 21th Floor, Tower B, Pingan 
International Financial Center, No. 1-3

Xinyuan South Road, Chaoyang District, 
Beijing

Attn: Xie Tao

Fax: 010-84381003

Postcode: 100027
	 
	 	 	 	 
	 

	 	If to the Assignee:	 	 
	 
	 	 	 	 
	 

	 	 	 	Mr. Xue Zhixin

Address: 25th Floor, Jin Gang Hotel,

No.91 Bing Zhou North Road,

Taiyuan City, Shanxi Province

Attn: Xue Zhixin

Fax: 0351-4727112

Postcode: 030001

	 	13.	 	Headings

The descriptive headings contained in this Assignment are for convenience of
reference only and shall not affect in any way the meaning or interpretation of this
Assignment.

	 	14.	 	Language

This Assignment is written in the Chinese language.

[SIGNATURE PAGES TO FOLLOW]

 

5

 

IN WITNESS WHEREOF, the Purchaser and the Seller have caused this Agreement to be executed by their
duly authorized representatives as of the date first written above.

	 	 	 	 	 	 	 	 	 	 	 
	ASSIGNOR	 	 	 	ASSIGNEE	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Aero-Biotech Science & Technology Co., Ltd.	 	 	 	Xue Zhixin	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:	 	/s/ Xie Tao	 	 	 	/s/ Xue Zhixin	 	 
	 	 	 	 	 	 	 	 	 
	 

	 	Name:
	 	Xie Tao	 	 	 	 	 	 
	 

	 	Title:
	 	Chief Executive Officer	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Seal:
	 	 	 	 	 	 	 	 	 	 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]